POLARIS INSIGHTS

Pfizer raises 2026 outlook to $62B-$64B revenue and $2. 95-$3. 05 adjusted EPS, targeting high single-digit revenue CAGR from 2028-2033

The development centers on pfizer raises 2026 outlook to $62B-$64B revenue and $2.95-$3.05 adjusted EPS, targeting.

More from the Markets desk